Back to results
US 5,328,921 AGranted
Aryl pyridinium compounds which are useful in treating shock
AssigneeAmerican Cyanamid Company
InventorsMichael P. Trova, Allan Wissner
Life of this patent
Estimating the term…
Abstract
The invention is aryl, amide, imide and carbamate pyridine antagonists of platelet activating factor.
Claims18
A composition of matter in dosage unit form which comprises a compound of the formula ##STR18## wherein (A) X is a divalent radical of:
- ##STR19## wherein p is the integer 0, 1, 2, or 3;
- n is the integer 0, 1, or 2;
- R.sub.6 is C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, C.sub.1 -C.sub.6 alkylamino, C.sub.1 -C.sub.6 alkoxy, phenyl, aminophenyl, substituted phenyl or substituted aminophenyl and the substituents are of one or more of the following C.sub.1 -C.sub.4 alkyl, C.sub.1 C.sub.4 alkoxy, halogen or trifluoromethyl, R.sub.7 is C.sub.1 -C.sub.25 alkyl, C.sub.2 -C.sub.25 alkenyl, phenyl or substituted phenyl and the substituents are C.sub.1 -C.sub.20 alkyl, C.sub.1 -C.sub.20 alkoxy, halogen or trifluoromethyl;
- R.sub.5 is --COR.sub.6 or --SO.sub.2 R.sub.7 wherein R.sub.6 and R.sub.7 are as previously described above
- (B) R.sub.1 is one or more substituents of the aromatic ring which may be the same or different and is
- (i) C.sub.1 -C.sub.25 alkyl, C.sub.2 -C.sub.25 alkenyl, C.sub.1 -C.sub.25 alkoxy, C.sub.2 -C.sub.25 alkenyloxy, C.sub.1 -C.sub.25 thioalkyl, phenyl, phenoxy, substituted phenyl or substituted phenoxy wherein the substituents are C.sub.1 -C.sub.20 alkyl, C.sub.1 -C.sub.20 alkoxy, halogen, or trifluoromethyl;
- (ii) halogen, trifluoromethyl, cyano, or nitro;
- (iii) --CO.sub.2 R.sub.7, --CONHR.sub.7, or --NHCOR.sub.7 wherein R.sub.7 is as previously described above;
- (C) the moiety R.sub.2 is one or more substituents of the pyridinium ring which may be in any position and are hydrogen, C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy, or halogen;
- (D) the heterocycle is bonded to the x-group at optionally the 2, 3, or 4 position,
- (E) the group R.sub.3 is C.sub.1 -C.sub.8 alkyl, C.sub.1 -C.sub.8 halogen substituted alkyl, benzyl, hydrogen, or N-oxide;
- and
- (F) Z.sup..crclbar. represents a pharmacologically acceptable anion in association with a pharmaceutically acceptable carrier.
10 more elements
A method of treating anaphylactic and septic shock in a mammal which comprises administering to said mammal an effective amount of a compound of ##STR20## wherein (A) X is a divalent radical of:
- ##STR21## wherein p is the integer 0, 1, 2, or 3;
- n is the integer 0, 1, or 2;
- R.sub.6 is C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, C.sub.1 -C.sub.6 alkylamino, C.sub.1 -C.sub.6 alkoxy, phenyl, aminophenyl, substituted phenyl or substituted aminophenyl and the substituents are of one or more of the following C.sub.1 -C.sub.4 alkyl, C.sub.1 C.sub.4 alkoxy, halogen or trifluoromethyl, R.sub.7 is C.sub.1 -C.sub.25 alkyl, C.sub.2 -C.sub.25 alkenyl, phenyl or substituted phenyl and the substituents are C.sub.1 -C.sub.20 alkyl, C.sub.1 -C.sub.20 alkoxy, halogen or trifluoromethyl;
- R.sub.5 is --COR.sub.6 or --SO.sub.2 R.sub.7 wherein R.sub.6 and R.sub.7 are as previously described above
- (B) R.sub.1 is one or more substituents of the aromatic ring which may be the same or different and is
- (i) C.sub.1 -C.sub.25 alkyl, C.sub.2 -C.sub.25 alkenyl, C.sub.1 -C.sub.25 alkoxy, C.sub.2 -C.sub.25 alkenyloxy, C.sub.1 -C.sub.25 thioalkyl, phenyl, phenoxy, substituted phenyl or substituted phenoxy wherein the substituents are C.sub.1 -C.sub.20 alkyl, C.sub.1 -C.sub.20 alkoxy, halogen, or trifluoromethyl;
- (ii) halogen, trifluoromethyl, cyano, or nitro;
- (iii) --CO.sub.2 R.sub.7, --CONHR.sub.7, or --NHCOR.sub.7 wherein R.sub.7 is as previously described above;
- (C) the moiety R.sub.2 is one or more substituents of the pyridinium ring which may be in any position and are hydrogen, C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy, or halogen;
- (D) the heterocycle is bonded to the x-group at optionally the 2, 3, or 4 position
- (E) the group R.sub.3 is C.sub.1 -C.sub.8 alkyl, C.sub.1 -C.sub.8 halogen substituted alkyl, benzyl, hydrogen, or N-oxide;
- and
- (F) Z.sup..crclbar. represents a pharmacologically acceptable anion.
10 more elements
Dependencies are inferred from the claim text.